Evidence map›Paper›PMID 31095905›Full record

ArticleACS synthetic biology2019

Genetic Compatibility and Extensibility of Orthogonal Replication.

Alex A Javanpour, Chang C Liu

Abstract read
In one paragraph

Article in ACS synthetic biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. In vivo hypermutation and continuous evolution.Nature reviews. Methods primers · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alex A JavanpourDepartment of Biomedical Engineering , University of California , Irvine , California 92697 , United States.
Chang C LiuDepartment of Biomedical Engineering , University of California , Irvine , California 92697 , United States.ORCID 0000-0002-3290-2880

Funding

Diversity Supplement for A High-Throughput Continuous Evolution System for in vivo Biosensor EngineeringDP2GM119163 · NIGMS · UNIVERSITY OF CALIFORNIA-IRVINE · PI LIU, CHANG C · 2015 to 2017
$2.5M
NIGMS NIH HHS DP2 GM119163
6 · The paper itself

Abstract

We recently developed an orthogonal replication system (OrthoRep) in yeast that allows for the rapid continuous mutagenesis of a special plasmid without mutating the genome. Although OrthoRep has been successfully applied to evolve several proteins and enzymes, the generality of OrthoRep has not yet been systematically studied. Here, we show that OrthoRep is fully compatible with all Saccharomyces cerevisiae strains tested, demonstrate that the orthogonal plasmid can encode genetic material of at least 22 kb, and report a CRISPR/Cas9-based method for expedient genetic manipulations of OrthoRep. It was previously reported that the replication system upon which OrthoRep is based is only stable in respiration-deficient S. cerevisiae strains that have lost their mitochondrial genome (ρ

Indexed as

CRISPR-Cas SystemsDNA ReplicationGene EditingGenetic VectorsMutagenesis, Site-DirectedPlasmidsSaccharomyces cerevisiaeSynthetic Biologycontinuous evolutionCRISPR/Cas9mutagenesisorthogonal replicationOrthoRepprotein-primed replication

Identifiers

PMID31095905
PMCPMC6778527

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.